# Serve Robotics Inc.: financial statements, quarterly

SERV · Nasdaq · CIK 1832483 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/serv.md) · [Financials](/companies/serv/financials.md) · [Filings](/companies/serv/filings.md) · [Insiders](/companies/serv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/serv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.1](/filings/0001832483-24-000029.md) | [0.0 d](/filings/0001832483-25-000010.md) | [0.9](/filings/0001832483-25-000038.md) | [0.5](/filings/0001832483-25-000089.md) | [0.2](/filings/0001832483-25-000112.md) | [0.2 d](/filings/0001832483-26-000010.md) | [0.4](/filings/0001832483-26-000019.md) | [0.6](/filings/0001832483-26-000035.md) | [0.7](/filings/0001832483-25-000112.md) | [0.9 d](/filings/0001832483-26-000010.md) | [3.0](/filings/0001832483-26-000019.md) | [3.2](/filings/0001832483-26-000035.md) |
| Cost of revenue | $m | [0.6](/filings/0001213900-23-087177.md) | [0.4 d](/filings/0001213900-24-018566.md) | [0.4](/filings/0001213900-24-043174.md) | [0.3](/filings/0001832483-25-000089.md) | [0.4](/filings/0001832483-25-000112.md) | [0.8 d](/filings/0001832483-26-000010.md) | [1.9](/filings/0001832483-26-000019.md) | [3.5](/filings/0001832483-26-000035.md) | [5.1](/filings/0001832483-25-000112.md) | [7.6 d](/filings/0001832483-26-000010.md) | [12.0](/filings/0001832483-26-000019.md) | [12.0](/filings/0001832483-26-000035.md) |
| Gross profit | $m | [(0.5)](/filings/0001832483-24-000029.md) | [(0.4) d](/filings/0001832483-25-000010.md) | [0.6](/filings/0001832483-25-000038.md) | [0.1](/filings/0001832483-25-000089.md) | [(0.2)](/filings/0001832483-25-000112.md) | [(0.7) d](/filings/0001832483-26-000010.md) | [(1.5)](/filings/0001832483-26-000019.md) | [(2.9)](/filings/0001832483-26-000035.md) | [(4.4)](/filings/0001832483-25-000112.md) | [(6.7) d](/filings/0001832483-26-000010.md) | [(9.0)](/filings/0001832483-26-000019.md) | [(8.8)](/filings/0001832483-26-000035.md) |
| Research and development | $m | [3.0](/filings/0001832483-24-000029.md) | [2.8 d](/filings/0001832483-25-000010.md) | [6.6](/filings/0001832483-25-000038.md) | [5.8](/filings/0001832483-25-000089.md) | [5.0](/filings/0001832483-25-000112.md) | [6.8 d](/filings/0001832483-26-000010.md) | [6.9](/filings/0001832483-26-000019.md) | [9.1](/filings/0001832483-26-000035.md) | [13.4](/filings/0001832483-25-000112.md) | [15.9 d](/filings/0001832483-26-000010.md) | [19.0](/filings/0001832483-26-000019.md) | [20.3](/filings/0001832483-26-000035.md) |
| Operating income | $m | [(5.6)](/filings/0001832483-24-000029.md) | [(6.8) d](/filings/0001832483-25-000010.md) | [(7.7)](/filings/0001832483-25-000038.md) | [(8.6)](/filings/0001832483-25-000089.md) | [(8.4)](/filings/0001832483-25-000112.md) | [(13.6) d](/filings/0001832483-26-000010.md) | [(15.0)](/filings/0001832483-26-000019.md) | [(22.6)](/filings/0001832483-26-000035.md) | [(34.8)](/filings/0001832483-25-000112.md) | [(40.3) d](/filings/0001832483-26-000010.md) | [(51.8)](/filings/0001832483-26-000019.md) | [(66.1)](/filings/0001832483-26-000035.md) |
| Interest expense | $m | [1.5](/filings/0001213900-23-087177.md) | [0.2 d](/filings/0001213900-24-018566.md) | [1.3](/filings/0001213900-24-043174.md) | [0.6](/filings/0001832483-25-000089.md) | [0.0](/filings/0001832483-25-000112.md) | [0.0 d](/filings/0001832483-26-000010.md) | [0.0](/filings/0001832483-26-000019.md) | [0.0](/filings/0001832483-26-000035.md) | [0.0](/filings/0001832483-25-000112.md) | [0.0 d](/filings/0001832483-26-000010.md) | [0.0](/filings/0001832483-26-000019.md) | [0.0](/filings/0001832483-26-000035.md) |
| Income tax | $m | [0.0](/filings/0001832483-24-000029.md) | [0.0 d](/filings/0001832483-25-000010.md) | [0.0](/filings/0001832483-25-000038.md) | [0.0](/filings/0001832483-25-000089.md) | [0.0](/filings/0001832483-25-000112.md) | [0.0 d](/filings/0001832483-26-000010.md) | [0.0](/filings/0001832483-26-000019.md) | [0.0](/filings/0001832483-26-000035.md) | [0.0](/filings/0001832483-25-000112.md) | [(3.7) d](/filings/0001832483-26-000010.md) | [(0.6)](/filings/0001832483-26-000019.md) | [(0.0)](/filings/0001832483-26-000035.md) |
| Net income | $m | [(7.6)](/filings/0001832483-24-000029.md) | [(7.1) d](/filings/0001832483-25-000010.md) | [(9.0)](/filings/0001832483-25-000112.md) | [(9.0)](/filings/0001832483-25-000112.md) | [(8.0)](/filings/0001832483-25-000112.md) | [(13.1) d](/filings/0001832483-26-000010.md) | [(13.2)](/filings/0001832483-26-000035.md) | [(20.9)](/filings/0001832483-26-000035.md) | [(33.0)](/filings/0001832483-25-000112.md) | [(34.3) d](/filings/0001832483-26-000010.md) | [(49.0)](/filings/0001832483-26-000035.md) | [(64.1)](/filings/0001832483-26-000035.md) |
| Diluted EPS | $ per share | [(0.41)](/filings/0001832483-24-000029.md) | not reported | [(0.37)](/filings/0001832483-25-000038.md) | [(0.27)](/filings/0001832483-25-000089.md) | [(0.20)](/filings/0001832483-25-000112.md) | not reported | [(0.23)](/filings/0001832483-26-000019.md) | [(0.36)](/filings/0001832483-26-000035.md) | [(0.54)](/filings/0001832483-25-000112.md) | not reported | [(0.65)](/filings/0001832483-26-000019.md) | [(0.80)](/filings/0001832483-26-000035.md) |
| Basic EPS | $ per share | [(0.41)](/filings/0001832483-24-000029.md) | not reported | [(0.37)](/filings/0001832483-25-000038.md) | [(0.27)](/filings/0001832483-25-000089.md) | [(0.20)](/filings/0001832483-25-000112.md) | not reported | [(0.23)](/filings/0001832483-26-000019.md) | [(0.36)](/filings/0001832483-26-000035.md) | [(0.54)](/filings/0001832483-25-000112.md) | not reported | [(0.65)](/filings/0001832483-26-000019.md) | [(0.80)](/filings/0001832483-26-000035.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.0](/filings/0001832483-25-000010.md) | not reported | [28.8](/filings/0001832483-24-000016.md) | [50.9](/filings/0001832483-24-000029.md) | [123](/filings/0001832483-26-000010.md) | [198](/filings/0001832483-25-000038.md) | [117](/filings/0001832483-25-000089.md) | [117](/filings/0001832483-25-000112.md) | [106](/filings/0001832483-26-000035.md) | [47.1](/filings/0001832483-26-000019.md) | [79.1](/filings/0001832483-26-000035.md) |
| Current assets | $m | [5.1](/filings/0001213900-23-087177.md) | [1.5](/filings/0001832483-25-000010.md) | [3.0](/filings/0001213900-24-043174.md) | [30.9](/filings/0001832483-24-000016.md) | [54.9](/filings/0001832483-24-000029.md) | [125](/filings/0001832483-26-000010.md) | [200](/filings/0001832483-25-000038.md) | [187](/filings/0001832483-25-000089.md) | [220](/filings/0001832483-25-000112.md) | [241](/filings/0001832483-26-000035.md) | [201](/filings/0001832483-26-000019.md) | [247](/filings/0001832483-26-000035.md) |
| Total assets | $m | [8.5](/filings/0001213900-23-087177.md) | [2.8](/filings/0001832483-25-000010.md) | [4.2](/filings/0001213900-24-043174.md) | [32.8](/filings/0001832483-24-000016.md) | [61.5](/filings/0001832483-24-000029.md) | [140](/filings/0001832483-26-000010.md) | [217](/filings/0001832483-25-000038.md) | [214](/filings/0001832483-25-000089.md) | [299](/filings/0001832483-25-000112.md) | [368](/filings/0001832483-26-000035.md) | [341](/filings/0001832483-26-000019.md) | [379](/filings/0001832483-26-000035.md) |
| Current liabilities | $m | [4.9](/filings/0001213900-23-087177.md) | [6.2](/filings/0001832483-25-000010.md) | [12.8](/filings/0001213900-24-043174.md) | [4.3](/filings/0001832483-24-000016.md) | [5.2](/filings/0001832483-24-000029.md) | [6.8](/filings/0001832483-26-000010.md) | [5.3](/filings/0001832483-25-000038.md) | [5.7](/filings/0001832483-25-000089.md) | [12.8](/filings/0001832483-25-000112.md) | [13.3](/filings/0001832483-26-000035.md) | [19.7](/filings/0001832483-26-000019.md) | [19.3](/filings/0001832483-26-000035.md) |
| Total liabilities | $m | [6.1](/filings/0001213900-23-087177.md) | [6.8](/filings/0001832483-25-000010.md) | [13.1](/filings/0001213900-24-043174.md) | [4.3](/filings/0001832483-24-000016.md) | [5.3](/filings/0001832483-24-000029.md) | [7.9](/filings/0001832483-26-000010.md) | [6.4](/filings/0001832483-25-000038.md) | [7.1](/filings/0001832483-25-000089.md) | [15.2](/filings/0001832483-25-000112.md) | [17.0](/filings/0001832483-26-000035.md) | [23.0](/filings/0001832483-26-000019.md) | [26.8](/filings/0001832483-26-000035.md) |
| Shareholders' equity | $m | [2.4](/filings/0001832483-24-000029.md) | [(4.0)](/filings/0001832483-26-000010.md) | [(8.8)](/filings/0001832483-25-000112.md) | [28.5](/filings/0001832483-25-000112.md) | [56.2](/filings/0001832483-25-000112.md) | [132](/filings/0001832483-26-000035.md) | [210](/filings/0001832483-26-000035.md) | [207](/filings/0001832483-26-000035.md) | [284](/filings/0001832483-25-000112.md) | [351](/filings/0001832483-26-000035.md) | [318](/filings/0001832483-26-000035.md) | [352](/filings/0001832483-26-000035.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(5.7) d](/filings/0001832483-24-000029.md) | [(3.7) d](/filings/0001832483-25-000010.md) | [(4.1)](/filings/0001832483-25-000038.md) | [(5.7) d](/filings/0001832483-25-000089.md) | [(5.5) d](/filings/0001832483-25-000112.md) | [(6.3) d](/filings/0001832483-26-000010.md) | [(9.5)](/filings/0001832483-26-000019.md) | [(16.0) d](/filings/0001832483-26-000035.md) | [(25.2) d](/filings/0001832483-25-000112.md) | [(29.6) d](/filings/0001832483-26-000010.md) | [(41.4)](/filings/0001832483-26-000019.md) | [(43.3) d](/filings/0001832483-26-000035.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001832483-24-000029.md) | [0.0 d](/filings/0001832483-25-000010.md) | [0.0](/filings/0001832483-25-000038.md) | [0.8 d](/filings/0001832483-25-000089.md) | [4.6 d](/filings/0001832483-25-000112.md) | [4.9 d](/filings/0001832483-26-000010.md) | [3.5](/filings/0001832483-26-000019.md) | [6.0 d](/filings/0001832483-26-000035.md) | [11.3 d](/filings/0001832483-25-000112.md) | [16.5 d](/filings/0001832483-26-000010.md) | [1.4](/filings/0001832483-26-000019.md) | [1.0 d](/filings/0001832483-26-000035.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.9](/filings/0001213900-23-087177.md) | [6.7](/filings/0001213900-24-043174.md) | [6.7](/filings/0001832483-24-000016.md) | [18.5](/filings/0001832483-24-000029.md) | [24.6](/filings/0001832483-25-000038.md) | [33.8](/filings/0001832483-25-000089.md) | [40.6](/filings/0001832483-25-000112.md) | [56.3](/filings/0001832483-26-000019.md) | [57.5](/filings/0001832483-26-000035.md) | [61.3](/filings/0001832483-25-000112.md) | [75.3](/filings/0001832483-26-000019.md) | [80.3](/filings/0001832483-26-000035.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 86,707,507 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001832483-26-000035.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.